RBC Capital analyst Leonid Timashev maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...

For the week, the S&P 500 logged a 3.1% decline, marking its worst performance since September. The Dow shed 2.4% over the ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

RBC Capital initiated coverage of Karman (KRMN) with an Outperform rating and $35 price target target. Karman is a leading merchant supplier ...

SBI Securities Co. Ltd. purchased a new position in Royal Bank of Canada (NYSE:RY – Free Report) (TSE:RY) in the 4th quarter, according to the company in its most recent 13F filing with the Securities ...

Canadian Natural Resources (TSE:CNQ – Free Report) (NYSE:CNQ) had its price target upped by Raymond James from C$51.00 to ...

Frontier Digital Ventures (FDV) has announced a change in its corporate advisor for the ongoing Strategic Review. The company ...

Bad news about the US economy travels fast. But examples of a slowing economy are potentially being blown out proportion.

Oil prices suddenly broke out of a months-long slumber last week to touch a three-year low. Now, traders are grappling with ...

A new wave of consumer activism is sweeping the nation, with protests and boycotts targeting controversial companies, forcing ...

Wall Street is on edge again, but the culprit this time isn’t inflation. Instead, equities investors large and small are ...

Investors don't think the wild swings in markets are over as uncertainty around President Trump's policies remains.